Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal denervation
MedTech
Boston Scientific snags renal denervation developer SoniVie
The acquisition sets up the company to potentially compete against FDA-approved devices from Medtronic and Recor Medical.
Conor Hale
Mar 3, 2025 11:15am
CMS to pay for renal denervation from Medtronic, Recor Medical
Nov 6, 2024 4:45am
Medtronic claims long-sought FDA approval in renal denervation
Nov 20, 2023 10:21am
Recor claims 1st FDA renal denervation approval for hypertension
Nov 8, 2023 10:07am
FDA panel backs ReCor, shuns Medtronic in renal denervation
Aug 24, 2023 11:28am
ReCor Medical taps Siemens Healthineers alum as CEO
Jan 3, 2023 12:04pm
